COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,974 Articles (22,604 medRxiv, 8,370 bioRxiv)

Most recent first Previous |  Page 735: Articles 7341-7350  | Next

Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro
Yadav, R., Courouble, V. V., Dey, S. K., Harrison, J. J. E. K., Timm, J., Hopkins, J. B., Slack, R. L., Sarafianos, S. G., Ruiz, F. X., Griffin, P. R., Arnold, E.
10.1101/2022.05.27.493767 — Posted: 2022-05-30
Modelling patterns of SARS-CoV-2 circulation in the Netherlands, August 2020-February 2022, revealed by a nationwide sewage surveillance program
van Boven, M., Hetebrij, W. A., Swart, A. M., Nagelkerke, E., van der Beek, R. F., Stouten, S., Hoogeveen, R. T., Miura, F., Kloosterman, A., van der Drift, A.-M. R., Welling, A., Lodder, W. J., de Roda Husman, A. M.
10.1101/2022.05.25.22275569 — Posted: 2022-05-30
Young age, student status and reported non-binary gender associate strongly with decreased functioning during Covid-19 pandemic in a university community.
Salokangas, R. K. R., From, T., Hietala, J.
10.1101/2022.05.30.22275757 — Posted: 2022-05-30
SARS-CoV-2 neutralising antibody activity in a highly vaccinated population: Longitudinal serology studies in Singapore
Clapham, H. E., Chia, W. N., Zhang, J., Wang, L.-F., Tam, C. C.
10.1101/2022.05.29.22275748 — Posted: 2022-05-30
Uncertainty Quantification in COVID-19 Detection Using Evidential Deep Learning
Khosravi, B., Faghani, S., Ashraf Ganjouei, A.
10.1101/2022.05.29.22275732 — Posted: 2022-05-29
Tixagevimab/Cilgavimab for Prevention of COVID-19 during the Omicron Surge: Retrospective Analysis of National VA Electronic Data
Young-Xu, Y., Epstein, L., Marconi, V. C., Davey, V., Zwain, G., Smith, J., Korves, C., Cunningham, F., Bonomo, R., Ginde, A. A.
10.1101/2022.05.28.22275716 — Posted: 2022-05-29
A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
Hernandez, M. M., Banu, R., Shrestha, P., Gonzalez-Reiche, A. S., van de Guchte, A., Farrugia, K., Sebra, R., PSP Study Group, M. S., Gitman, M. R., Nowak, M. D., Cordon-Cardo, C., Simon, V., van Bakel, H., Sordillo, E. M., Luna, N., Ramirez, A., Castaneda, S., Patino, L. H., Ballesteros, N., Munoz, M., Ramirez, J. D., Paniz Mondolfi, A. E.
10.1101/2022.05.28.22275691 — Posted: 2022-05-29
Comparison of the burnout among medical residents before and during the pandemic: not more exhausted but less accomplished
Kücükali, H., Türkoglu, S. N., Hasanli, S., Dayanır Cok, F. N., Culpan, H. C., Hayran, O.
10.1101/2022.05.28.22275707 — Posted: 2022-05-29
Identifying COVID-19 phenotypes using cluster analysis and assessing their clinical outcomes
Yamga, E., Mullie, L., Durand, M., Cadrin-Chenevert, A., Tang, A., Montagnon, E., Chartrand-Lefebvre, C., Chasse, M.
10.1101/2022.05.27.22275708 — Posted: 2022-05-29
The connection between COVID-19 vaccine abundance, vaccination coverage, and public trust in government across the globe
G. Monfared, I.
10.1101/2022.05.24.22275504 — Posted: 2022-05-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).